Syndicate This week's upcoming IPO's and secondary offerings

Week of June 29 to July 3, 2024

This Day's Priced Deals: June 30th, 2020

Symbol

Issuer

Type

Price

Managers

ADTX

Aditx Therapeutics
Aditx Therapeutics
IPO
Priced: $9.00
1.227M
DAWS

Intra-day pricing

Managers: DAWS

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
GRWG

GrowGeneration
GrowGeneration
Secondary
Priced: $5.60
7.5M
Oppenheimer,...

Pricing after close
Deal analysis and details

Managers: Oppenheimer, Ladenburg, LAKE

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
IIPR

Innovative Industrial Properties
Innovative Industrial Properties
Spot Secondary
Priced: $83.85
2.683M
BTIG,...

Pricing after close
Deal analysis and details

Managers: BTIG, Roth MKM, Compass Point, Ladenburg

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
LQDA

Liquidia Technologies
Liquidia Technologies
Spot Secondary
Priced: $8.00
9.375M
Jefferies,...

Pricing after close
Deal analysis and details

Managers: Jefferies, Needham, Wedbush

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

This Week's Priced Deals

06/29 - Monday

Symbol

Issuer

Type

Price

Managers

GRWG

GrowGeneration
GrowGeneration
Secondary
Priced: $5.60
7.5M
Oppenheimer,...

Pricing after close
Deal analysis and details

Managers: Oppenheimer, Ladenburg, LAKE

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
IIPR

Innovative Industrial Properties
Innovative Industrial Properties
Spot Secondary
Priced: $83.85
2.683M
BTIG,...

Pricing after close
Deal analysis and details

Managers: BTIG, Roth MKM, Compass Point, Ladenburg

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
LQDA

Liquidia Technologies
Liquidia Technologies
Spot Secondary
Priced: $8.00
9.375M
Jefferies,...

Pricing after close
Deal analysis and details

Managers: Jefferies, Needham, Wedbush

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

06/30 - Tuesday

Symbol

Issuer

Type

Price

Managers

ADTX

Aditx Therapeutics
Aditx Therapeutics
IPO
Priced: $9.00
1.227M
DAWS

Intra-day pricing

Managers: DAWS

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
DNB

Dun & Bradstreet
Dun & Bradstreet
IPO
Priced: $22.00
78.3M
Goldman Sachs & BofA,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: Goldman Sachs & BofA, JPMorgan, Barclays, Citi, Credit Suisse, HSBC, Jefferies, RBC Capital, Wells Fargo, Deutsche Bank, BMO Capital, SUNT, TD Securities, Raymond James, Stephens, William Blair, Academy, Loop Capital

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
AHCO

AdaptHealth
AdaptHealth
Secondary
Priced: $15.50
8M
Jefferies,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: Jefferies, Deutsche Bank, RBC Capital & Stifel, Canaccord, Regions Securities

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
CRSP

Crispr Therapeutics
Crispr Therapeutics
Secondary
Priced: $70.00
6.429M
Goldman Sachs,...

Pricing after close
Deal analysis and details

Managers: Goldman Sachs, BofA & Jefferies

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
NOVA

Sunnova Energy
Sunnova Energy
Secondary
Priced: $16.50
6M
JPMorgan,...

Pricing after close
Deal analysis and details

Managers: JPMorgan, BofA, Credit Suisse & Goldman Sachs

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
TA

TravelCenters
TravelCenters
Secondary
Priced: $14.00
6.1M
Citi,...

Pricing after close
Deal analysis and details

Managers: Citi, BMO Capital, B. Riley & BTIG

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
XLRN

Acceleron
Acceleron
Secondary
Priced: $92.50
4.86M
JPMorgan,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: JPMorgan, Leerink & TD Cowen, Barclays, Credit Suisse, Piper Sandler

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
CHMA

Chiasma
Chiasma
Spot Secondary
Priced: $4.00
17.5M
Jefferies,...

Pricing after close
Deal analysis and details

Managers: Jefferies, Piper Sandler & Cantor Fitzgerald

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
DENN

Denny's
Denny's
Spot Secondary
Priced: $9.15
8M
Wells Fargo,...

Pricing after close
Deal analysis and details

Managers: Wells Fargo, Regions Securities, Citizens Capital Markets

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

07/01 - Wednesday

Symbol

Issuer

Type

Price

Managers

ACCD

Accolade
Accolade
IPO
Priced: $22.00
10.023M
Goldman Sachs,...

Pricing after close
Deal analysis and details

Managers: Goldman Sachs, Morgan Stanley & BofA, Piper Sandler, Credit Suisse, William Blair, Baird, Leerink

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
LMND

Lemonade
Lemonade
IPO
Priced: $29.00
11M
Goldman Sachs,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: Goldman Sachs, Morgan Stanley, Allen & Co. & Barclays, JMP Securities, Oppenheimer, William Blair, LION

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
EVSI

Envision Solar
Envision Solar
Secondary
Priced: $8.25
1.212M
Maxim,...

Pricing after close

Managers: Maxim, Joseph Gunnar

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
IIVI

II-VI
II-VI
Secondary
Priced: $43.00
9.302M
BofA,...

Pricing after close
Deal analysis and details

Managers: BofA, JPMorgan & Citi

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
XP

XP Inc.
XP Inc.
Secondary
Priced: $42.50
19.53M
XP Investimentos,...

Pricing after close
Deal analysis and details

Managers: XP Investimentos, Morgan Stanley, Goldman Sachs & JPMorgan

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
BLFS

BioLife Solutions
BioLife Solutions
Spot Secondary
Priced: $14.50
5.175M
TD Cowen,...

Pricing after close
Deal analysis and details

Managers: TD Cowen, Oppenheimer & Stephens

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
DSS

Document Security
Document Security
Spot Secondary
Priced: $6.25
1.03M
Aegis

Pricing after close
Deal analysis and details

Managers: Aegis

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
NLTX

Neoleukin Therapeutics
Neoleukin Therapeutics
Spot Secondary
Priced: $15.25
5M
Canaccord,...

Pricing after close
Deal analysis and details

Managers: Canaccord, H.C. Wainwright

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
ZOM

Zomedica
Zomedica
Spot Secondary
Priced: $.16
187.5M
H.C. Wainwright

Pricing after close

Managers: H.C. Wainwright

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

Get Full Fly Access